Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity
- PMID: 16385140
- DOI: 10.1385/MN:32:3:237
Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity
Abstract
The ionotropic alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor is densely distributed in the mammalian brain and is primarily involved in mediating fast excitatory synaptic transmission. Recent studies in both heterologous expression systems and cultured neurons have shown that the AMPA receptor can be phosphorylated on their subunits (GluR1, GluR2, and GluR4). All phosphorylation sites reside at serine, threonine, or tyrosine on the intracellular C-terminal domain. Several key protein kinases, such as protein kinase A, protein kinase C, Ca2+/calmodulin-dependent protein kinase II, and tyrosine kinases (Trks; receptor or nonreceptor family Trks) are involved in the site-specific regulation of the AMPA receptor phosphorylation. Other glutamate receptors (N-methyl-d-aspartate receptors and metabotropic glutamate receptors) also regulate AMPA receptors through a protein phosphorylation mechanism. Emerging evidence shows that as a rapid and short-term mechanism, the dynamic protein phosphorylation directly modulates the electrophysiological, morphological (externalization and internalization trafficking and clustering), and biochemical (synthesis and subunit composition) properties of the AMPA receptor, as well as protein-protein interactions between the AMPA receptor subunits and various intracellular interacting proteins. These modulations underlie the major molecular mechanisms that ultimately affect many forms of synaptic plasticity.
Similar articles
-
Alterations in GluR2 AMPA receptor phosphorylation at serine 880 following group I metabotropic glutamate receptor stimulation in the rat dorsal striatum.J Neurosci Res. 2010 Apr;88(5):992-9. doi: 10.1002/jnr.22275. J Neurosci Res. 2010. PMID: 19908285
-
Characterization of phosphorylation sites on the glutamate receptor 4 subunit of the AMPA receptors.J Neurosci. 1999 Jun 15;19(12):4748-54. doi: 10.1523/JNEUROSCI.19-12-04748.1999. J Neurosci. 1999. PMID: 10366608 Free PMC article.
-
Phosphorylation of glutamate receptors: a potential mechanism for the regulation of receptor function and psychostimulant action.J Neurosci Res. 2006 Dec;84(8):1621-9. doi: 10.1002/jnr.21050. J Neurosci Res. 2006. PMID: 16983660 Review.
-
SAP97 is associated with the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor GluR1 subunit.J Biol Chem. 1998 Jul 31;273(31):19518-24. doi: 10.1074/jbc.273.31.19518. J Biol Chem. 1998. PMID: 9677374
-
Modification of glutamate receptor channels: molecular mechanisms and functional consequences.Naturwissenschaften. 1999 Apr;86(4):177-86. doi: 10.1007/s001140050593. Naturwissenschaften. 1999. PMID: 10331215 Review.
Cited by
-
Naltrexone Facilitates Learning and Delays Extinction by Increasing AMPA Receptor Phosphorylation and Membrane Insertion.Biol Psychiatry. 2016 Jun 1;79(11):906-16. doi: 10.1016/j.biopsych.2015.04.019. Epub 2015 May 2. Biol Psychiatry. 2016. PMID: 26049209 Free PMC article.
-
Hydrogen Sulfide Promotes Surface Insertion of Hippocampal AMPA Receptor GluR1 Subunit via Phosphorylating at Serine-831/Serine-845 Sites Through a Sulfhydration-Dependent Mechanism.CNS Neurosci Ther. 2016 Sep;22(9):789-98. doi: 10.1111/cns.12585. Epub 2016 Jul 6. CNS Neurosci Ther. 2016. PMID: 27380893 Free PMC article.
-
Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid.Mol Cell Proteomics. 2019 Mar;18(3):546-560. doi: 10.1074/mcp.RA118.001290. Epub 2019 Jan 3. Mol Cell Proteomics. 2019. PMID: 30606734 Free PMC article.
-
Enhanced transmission at a spinal synapse triggered in vivo by an injury signal independent of altered synaptic activity.J Neurosci. 2007 Nov 21;27(47):12851-9. doi: 10.1523/JNEUROSCI.1997-07.2007. J Neurosci. 2007. PMID: 18032657 Free PMC article.
-
Combined treatment with a selective PDE10A inhibitor TAK-063 and either haloperidol or olanzapine at subeffective doses produces potent antipsychotic-like effects without affecting plasma prolactin levels and cataleptic responses in rodents.Pharmacol Res Perspect. 2018 Feb;6(1):e00372. doi: 10.1002/prp2.372. Pharmacol Res Perspect. 2018. PMID: 29417763 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous